New Delhi, Jan 30 (IANS) While several pharmaceutical companies have mRNA vaccines in late-stage development for other infectious diseases, Moderna…
Browsing: mRNA
Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer upgraded the stock to the equivalent…
U.S. stocks were giving back most of their earlier gains on Thursday afternoon, with the Dow Jones Industrial Average up…
Moderna Inc.’s stock soared 14% early Thursday after the biotech company and partner Merck & Co. announced positive data from…
Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on…
U.S. stock index futures were slightly higher in premarket trading early Wednesday after Treasuries recovered from a sharp sell-off that…
It may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard against…
The Centers for Disease Control and Prevention on Tuesday recommended updated COVID-19 vaccines for people 6 months of age and…
The U.S. Food and Drug Administration on Monday approved updated COVID vaccines from Moderna Inc. and Pfizer Inc., opening the…
The broad U.S. stock indexes are weighted by market capitalization, which can work out well during a bull market, as…